Latest News
Rideshare Cuts Colon Cancer Deaths, Saves Costs After Abnormal FIT, Study Finds
Providing rideshare transportation for patients with abnormal fecal immunochemical test (FIT) results could be a cost-saving strategy to improve color...
Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis
Methotrexate, a cornerstone treatment for rheumatoid arthritis (RA), may also offer an unexpected cardiovascular benefit.1 New findings from a control...
The Totality of Evidence of Ustekinumab Biosimilar SB17
A review article outlined the totality of evidence supporting efficacy and safety of SB17, a ustekinumab biosimilar. SB17 is a monoclonal antibody tar...
Mobile Text Messages Improve Diabetes, Heart Risk Control
Simple text reminders may help patients with type 2 diabetes (T2D) take control of their health, according to one study. A new clinical trial in China...
FDA Urges Child-Resistant Packaging for Nicotine Pouches
The FDA is calling on nicotine pouch manufacturers to adopt child-resistant packaging after a surge in accidental poisonings among young children, acc...
Reductions in Drug Prices Possible With Most Favored Nation Executive Order but Large Reductions Unrealistic: Q&A With Kathy Oubre, MS
In the first part of this Q&A, Kathy Oubre, MS, chief executive officer of the Pontchartrain Cancer Center, explained what the executive order signed...
RNA CAR T Shows Promise for Myasthenia Gravis
Development of B-cell maturation antigen (BCMA)–directed RNA chimeric antigen receptor T-cell therapy (rCAR T) to treat refractory generalized myasthe...
GLP-1s Reduced Adverse Heart Failure Events by 40% in Patients With HFpEF
Patients with heart failure with preserved ejection fraction (HFpEF) who initiated semaglutide or tirzepatide saw a 40% risk reduction in combined hos...
West Coast States Form Alliance to Provide Public Health Recommendations
In a joint move they say aims to safeguard scientific integrity, Democratic governors Bob Ferguson of Washington, Gavin Newsom of California, and Tina...
Discussing Baricitinib for Alopecia Areata
Opinion Video Author(s): Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of barici...
Rideshare Cuts Colon Cancer Deaths, Saves Costs After Abnormal FIT, Study Finds
Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis
The Totality of Evidence of Ustekinumab Biosimilar SB17
Mobile Text Messages Improve Diabetes, Heart Risk Control
FDA Urges Child-Resistant Packaging for Nicotine Pouches
Reductions in Drug Prices Possible With Most Favored Nation Executive Order but Large Reductions Unrealistic: Q&A With Kathy Oubre, MS
RNA CAR T Shows Promise for Myasthenia Gravis
GLP-1s Reduced Adverse Heart Failure Events by 40% in Patients With HFpEF
West Coast States Form Alliance to Provide Public Health Recommendations
Discussing Baricitinib for Alopecia Areata
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago